> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Akcea Therapeutics NDA in May
- URL: https://www.fdaweb.com/panel-to-review-akcea-therapeutics-nda-in-may/
- Published: 2018-02-16T12:00:00.000Z
- Updated: 2026-09-14T23:23:11.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140786

*Federal Register* notice: FDA has announced a 5/10 Endocrinologic and Metabolic Drugs Advisory Committee meeting. Panel members are scheduled to discuss the safety and efficacy of an Akcea Therapeutics NDA for volanesoren solution for subcutaneous injection, indicated as an adjunct to diet for treating patients with familial chylomicronemia syndrome. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03237.pdf?ref=fdaweb.com).